Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

Atux Iskay presents preclinical data on PP2A activator ATUX-792 in IPF

May 30, 2022

Sichuan Haisco Pharmaceutical patents ENPP2 inhibitors

May 30, 2022

Pendrin inhibitor ARBM-201 reduces lung injury in acute respiratory distress syndrome model

May 30, 2022

FDA awards orphan drug designation to TTI-101 for IPF

May 27, 2022

ILDONG Pharmaceutical synthesizes new CFTR modulators and/or PDE4 inhibitors

May 18, 2022

AstraZeneca selects IPF target under drug discovery collaboration with BenevolentAI

May 17, 2022

Vertex Pharmaceuticals patents CFTR modulators

May 6, 2022

ALTA-2530 shows preclinical efficacy as potential treatment of bronchiolitis obliterans syndrome

May 5, 2022

Vertex Pharmaceuticals describes new CFTR modulators

May 5, 2022

Vertex Pharmaceuticals discovers CFTR modulators

May 2, 2022

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 4, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for April 4, 2025.
Biopharma exempt from US reciprocal tariffs, but not untouched
BioWorld
At first glance, it appears that biopharmaceuticals dodged the latest U.S. tariff bullet; med-tech, not so much. According to the executive order President Donald...
ADPD 2025: Unlocking GLP-1's potential in neurodegeneration
BioWorld
At the recently launched Alzheimer’s & Parkinson’s Diseases Conference held in Vienna, Lotte Bjerre Knudsen from Novo Nordisk A/S, who has extensive experience in...
Checkpoint inhibitor journey traces Chinese firms’ path to global revenue
BioWorld
Chinese pharmaceutical companies are making significant inroads into the global oncology market, particularly with the development and approval of immune...